Radiation Therapy Quality Assurance Phantoms Market Size to Reach USD 36.4 Million by 2028 | Rising Prevalence of Cancers and Increasing Demand for Phantoms for Tumor and Cancer Treatment is Driving Revenue Growth, says Emergen Research Vancouver, British Columbia, Feb. 08, 2021 (GLOBE NEWSWIRE) -- The global radiation therapy quality assurance (QA) phantoms market is expected to reach a market size of USD 36.4 Million by 2028 at a...

Carl Zeiss Meditec's INTRABEAM Targeted Intraoperative Radiotherapy System Demonstrates that Single-dose Radiation is Equivalent to Prolonged Courses of Post-operative Radiation for Early Breast Cancer Treatment CHICAGO, IL--(Marketwire - June 7, 2010) -  Carl Zeiss Meditec announced that outcomes for the TARGIT-A multicenter clinical trial, which used the INTRABEAM® System to deliver a single dose...

Clinical Data for Carl Zeiss Meditec's INTRABEAM Targeted Intraoperative Radiotherapy System for Breast Cancer to Be Presented at ASCO 2010 JENA, GERMANY and DUBLIN, CA--(Marketwire - May 26, 2010) -  Carl Zeiss Meditec announced that the TARGIT-A (TARGeted Intra-operative radiation Therapy) multicenter clinical trial that used the...